2,3-Quinoxalinedione,1,4-dihydro-,monooxime(9CI)结构式
|
常用名 | 2,3-Quinoxalinedione,1,4-dihydro-,monooxime(9CI) | 英文名 | 2,3-Quinoxalinedione,1,4-dihydro-,monooxime(9CI) |
---|---|---|---|---|
CAS号 | 177944-77-3 | 分子量 | 177.16000 | |
密度 | N/A | 沸点 | N/A | |
分子式 | C8H7N3O2 | 熔点 | N/A | |
MSDS | N/A | 闪点 | N/A |
英文名 | 2-(hydroxymethylidene)-1,4-dihydropyrido[2,3-b]pyrazin-3-one |
---|
分子式 | C8H7N3O2 |
---|---|
分子量 | 177.16000 |
精确质量 | 177.05400 |
PSA | 82.03000 |
LogP | 0.24060 |
~41% 2,3-Quinoxaline... 177944-77-3 |
文献:State of Oregon, Acting by and through the Oregon State Board of Higher Education, Acting for and on Behalf of the Oregon Health Sciences University and the University of Oregon; Acea Pharmaceuticals, Inc.; The Regents of the University of California Patent: US5597922 A1, 1997 ; US 5597922 A |
~0% 2,3-Quinoxaline... 177944-77-3 |
文献:State of Oregon, Acting by and through the Oregon State Board of Higher Education, Acting for and on Behalf of the Oregon Health Sciences University and the University of Oregon; Acea Pharmaceuticals, Inc.; The Regents of the University of California Patent: US5597922 A1, 1997 ; US 5597922 A |